[1]查晴,肖凡,张倩茹,等.主动脉瓣膜钙化中胰高血糖素样肽-1对Notch1-Sox9信号通路的调控作用[J].国际心血管病杂志,2021,06:370-375,379.
　ZHA Qing,XIAO Fan,ZHANG QianRu,et al.The regulatory effects of glucagon-like peptide-1 on Notch1-Sox9 signaling pathway in aortic valve calcification[J].International Journal of Cardiovascular Disease,2021,06:370-375,379.

点击复制

主动脉瓣膜钙化中胰高血糖素样肽-1对Notch1-Sox9信号通路的调控作用(PDF)

参考文献/References

[1] de Oliveira Sá MPB, Cavalcanti LRP, Perazzo áM, et al. Calcific aortic valve stenosis and atherosclerotic calcification[J]. Curr Atheroscler Rep, 2020, 22(2):2.
[2] Kostyunin AE, Yuzhalin AE, Ovcharenko EA, et al. Development of calcific aortic valve disease: Do we know enough for new clinical trials?[J]. J Mol Cell Cardiol, 2019, 132:189-209.
[3] Carpenter TO, Shaw NJ, Portale AA, et al. Rickets[J]. Nat Rev Dis Primers, 2017, 3:17101.
[4] Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications[J]. Circ Res, 2006, 99(10):1044-1059.
[5] Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis[J]. Nat Rev Dis Primers, 2016, 2:16006.
[6] Chaudhari S, Yazdizadeh Shotorbani P, Tao Y, et al. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and the pathway involved[J]. Am J Physiol Renal Physiol, 2020, 318:F1478-F1488.
[7] Laguna-Fernandez A, Carracedo M, Jeanson G, et al. Iron alters valvular interstitial cell function and is associated with calcification in aortic stenosis[J]. Eur Heart J, 2016, 37(47):3532-3535.
[8] Schlotter F, Halu A, Goto S, et al. Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease[J]. Circulation, 2018, 138(4):377-393.
[9] Simard L, Côté N, Dagenais F, et al. Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: Is valvular fibrosis the explanation?[J]. Circ Res, 2017, 120(4):681-691.
[10] Choi JH, Kim SJ, Kwon SK, et al. Renal tubular glucagon-like peptide-1 receptor expression is increased in early sepsis but reduced in chronic kidney disease and sepsis-induced kidney injury[J]. Int J Mol Sci, 2019, 20(23):6024.
[11] Kanda R, Hiraike H, Wada-Hiraike O, et al. Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer [J]. BMC Cancer, 2018, 18(1):657.
[12] Malbert CH, Chauvin A, Horowitz M, et al. Glucose sensing mediated by portal glucagon-like peptide 1 receptor is markedly impaired in insulin-resistant obese animals[J]. Diabetes, 2021, 70(1):99-110.
[13] Naruse G, Kanamori H, Yoshida A, et al. The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling[J]. Cardiovasc Res, 2019, 115(13):1873-1885.
[14] Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1[J]. Cell Metab, 2018, 27(4):740-756.
[15] Liang YL, Khoshouei M, Glukhova A, et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex[J]. Nature, 2018, 555(7694):121-125.
[16] Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2012, 8(12):728-742.
[17] Zanotto C, Hansen F, Galland F, et al. Glutamatergic alterations in STZ-induced diabetic rats are reversed by exendin-4[J]. Mol Neurobiol, 2019, 56(5):3538-3551.
[18] Shan Y, Tan S, Lin Y, et al. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke[J]. J Neuroinflammation, 2019, 16(1):242.
[19] Peacock JD, Levay AK, Gillaspie DB, et al. Reduced sox9 function promotes heart valve calcification phenotypes in vivo[J]. Circ Res, 2010, 106(4):712-719.
[20] Thomas PS, Sridurongrit S, Ruiz-Lozano P, et al. Deficient signaling via Alk2(Acvr1)leads to bicuspid aortic valve development[J]. PLoS One 2012, 7(4):e35539.
[21] Fiorotto R, Raizner A, Morell CM, et al. Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice[J]. J Hepatol, 2013, 59(1):124-130.
[22] Zhang X, Xu Y, Chen JM, et al. Huang Qi decoction prevents BDL-induced liver fibrosis through inhibition of notch signaling activation[J]. Am J Chin Med, 2017, 45(1):85-104.
[23] Toshima T, Watanabe T, Narumi T, et al. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling[J]. Cardiovasc Res, 2020, 116(5):983-994.
[24] Liu C, Cheng X, Chen J, et al. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration[J]. Theranostics, 2019, 9(13):3840-3852.
[25] Zanotti S, Canalis E. Interleukin 6 mediates selected effects of Notch in chondrocytes[J]. Osteoarthritis Cartilage, 2013, 21(11):1766-1773.

备注/Memo

备注/Memo:

基金项目:上海交通大学医学院附属第九人民医院基础研究助推计划(JYZZ100)
通信作者:刘艳,E-mail:liuyan_ivy@126.com

常用功能